Singapore develops world-first blood test to monitor cancer treatment success
Singapore develops world-first blood test to monitor cancer treatment success 09 June 2021 | News The ExoSCOPE test accurately classifies disease status and determines treatment outcome within 24 hours after the start of treatment
Image credit- NUS Singapore
Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working, within one day after the start of the treatment.
Assistant Professor Shao Huilin and her research team from the Department of Biomedical Engineering and Institute for Health Innovation & Technology (iHealthtech) at the National University of Singapore (NUS) have developed a technology that is accurate, less invasive and significantly brings forward the evaluation window, by using liquid biopsies.
Melina R. Kibbe named dean of UVA School of Medicine
Published Wednesday, Jun. 9, 2021, 10:24 am
Join AFP s 100,000+ followers on Facebook
Purchase a subscription to AFP
Subscribe to AFP podcasts on iTunes and Spotify
News, press releases, letters to the editor: augustafreepress2@gmail.com
The University of Virginia has named pioneering physician leader Melina R. Kibbe, MD, as 17th dean of the UVA School of Medicine and chief health affairs officer for UVA Health.
Dr. Kibbe comes to UVA effective Sept. 15 from her role as the Colin G. Thomas Jr. Distinguished Professor and Chair of the Department of Surgery at the University of North Carolina at Chapel Hill, where she also holds an appointment in the Department of Biomedical Engineering.
Join us every Friday at 12:00 p.m. EDT for BME Breaks, Columbia University's weekly webinar series hosted by the Department of Biomedical Engineering. Don't miss the opportunity each week to hear from global leaders in Biomedical Engineering research!
ABOUT THE JUNE 4 WEBINAR
A Less Artificial Intelligence